
Sign up to save your podcasts
Or


Dr. Casey Grover explores the history, neuroscience, and treatment approaches for methamphetamine use disorder, highlighting how methamphetamine releases more dopamine than any other known substance.
• Methamphetamine was widely used during World War II by German, Japanese, and Allied forces to enhance performance
• Modern meth production shifted from ephedra to P2P method, creating cheaper, more potent meth with worse psychiatric effects
• Meth causes dopamine release up to 1,400 ng/dL of dopamine compared to cocaine (400), sex (200), and food (150), severely damaging reward centers
• Many methamphetamine users have undiagnosed ADHD and are inadvertently self-medicating
• Effective medications include bupropion, topiramate, atomoxetine, viloxazine, guanfacine, and mirtazapine
• Contingency management (reward-based incentives) shows significant efficacy for methamphetamine addiction treatment
• Combination therapies using bupropion with naltrexone show promise for reducing meth use
• Treating underlying mental health conditions and providing housing/social support remains essential for recovery
To contact Dr. Grover: [email protected]
By Casey Grover, MD, FACEP, FASAM4.9
5454 ratings
Dr. Casey Grover explores the history, neuroscience, and treatment approaches for methamphetamine use disorder, highlighting how methamphetamine releases more dopamine than any other known substance.
• Methamphetamine was widely used during World War II by German, Japanese, and Allied forces to enhance performance
• Modern meth production shifted from ephedra to P2P method, creating cheaper, more potent meth with worse psychiatric effects
• Meth causes dopamine release up to 1,400 ng/dL of dopamine compared to cocaine (400), sex (200), and food (150), severely damaging reward centers
• Many methamphetamine users have undiagnosed ADHD and are inadvertently self-medicating
• Effective medications include bupropion, topiramate, atomoxetine, viloxazine, guanfacine, and mirtazapine
• Contingency management (reward-based incentives) shows significant efficacy for methamphetamine addiction treatment
• Combination therapies using bupropion with naltrexone show promise for reducing meth use
• Treating underlying mental health conditions and providing housing/social support remains essential for recovery
To contact Dr. Grover: [email protected]

142 Listeners

260 Listeners

3,347 Listeners

154 Listeners

31 Listeners

1,337 Listeners

8,600 Listeners

285 Listeners

564 Listeners

313 Listeners

29,238 Listeners

41,511 Listeners

151 Listeners

31 Listeners

9 Listeners